DryShips Inc. (NASDAQ:DRYS) on Mar 26, 2014 announced that Ocean Rig has closed the offering of $500.0 million in aggregate principal amount of 7.25% senior notes due 2019 (the “Notes”). The Notes were sold in a private offering within the United States to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain other persons outside of the United States in reliance on Regulation S under the Securities Act. Ocean Rig will use the net proceeds from the offering of the Notes together with other available funds to fund the repurchase or redemption of its 9.5% Senior Unsecured Notes due 2016, for which it is conducting a concurrent tender offer, and to pay related fees and expenses. As of 5:00 p.m., New York City time, on March 21, 2014, approximately 92.5% (or $462.3 million in aggregate principal amount) of the 9.5% Senior Unsecured Notes due 2016 had been tendered in the tender offer. DryShips Inc. (NASDAQ:DRYS) shares after opening at $3.39 on last trade day and at the end of the day closed at $3.22. Company price to sales ratio in past twelve months was calculated as 0.84 and price to cash ratio as 2.10. DryShips Inc. (NASDAQ:DRYS) showed a negative weekly performance of -10.06%.
Office Depot Inc. (NYSE:ODP) posted dismal fourth quarter and full year results, the company’s stock has been trading on a downward trend. The increase in the intensity of online competition continues to hurt the company’s sales, which has continued to drop. A loss of 3 cents a share in the fourth quarter was a clear indication of things not being well in the global supplier of office products. Office Depot Inc (NYSE:ODP) shares fell -2.41% in last trading session and ended the day on $4.05. ODP return on equity ratio is recorded as -10.90% and its return on assets is -2.40%. Office Depot Inc (NYSE:ODP) yearly performance is -23.44%.
Investment analysts at HC Wainwright initiated coverage on shares of Ariad Pharmaceuticals (NASDAQ:ARIA) in a note issued to investors on Tuesday, StockRatingsNetwork reports. The firm set a “buy” rating and a $14.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 84.21% from the company’s current price. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares moved down -1.16% in last trading session and was closed at $7.67, while trading in range of $7.56 – $8.00. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) year to date (YTD) performance is 12.46%.
Analysts at Maxim Group dropped their price target on shares of Aeropostale (NYSE:ARO) from $9.00 to $6.00 in a research report issued to clients and investors on Thursday, Analyst Ratings Net reports. The firm currently has a “positive” rating on the stock. Maxim Group’s target price would indicate a potential upside of 7.53% from the stock’s previous close. Aeropostale Inc (NYSE:ARO) weekly performance is -14.26%. On last trading day company shares ended up $4.99. Aeropostale Inc (NYSE:ARO) distance from 50-day simple moving average (SMA50) is -27.18%. Analysts mean target price for the company is $7.37.